EraCal Therapeutics Revenue
Biotechnology Research • 
Basel, Basel, Switzerland • 1-10 Employees
$
EraCal Therapeutics revenue & valuation
| Annual revenue | $2,000,000 |
| Revenue per employee | $500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,400,000 |
| Total funding | No funding |
Key Contact at EraCal Therapeutics
Pauline Pfirter
Member Board of Directors
Company overview
| Headquarters | Aeschengraben 13, Basel, BS 4051, CH |
| Website | |
| NAICS | 541714 |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About EraCal Therapeutics
The biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
EraCal Therapeutics Tech Stack
Discover the technologies and tools that power EraCal Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
United States
Germany
United Arab Emirates
Frequently asked questions
EraCal Therapeutics is located in Basel, Basel, CH.
EraCal Therapeutics generates an estimated annual revenue of $2,000,000. This revenue figure reflects the company's market position and business performance in its industry.
EraCal Therapeutics has an estimated valuation of $6,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
EraCal Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
EraCal Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
